Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00128167 · ClinicalTrials.gov registry record · Phase 3
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
A Phase 3 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 3
- Development phase
- 8,500
- Enrollment target
NCT00128167: Completed Phase 3 study, sponsored by MedImmune.
NCT00128167 is a Phase 3 study that has completed, run by MedImmune. The registered enrollment target is 8,500 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1002% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00128167, a Phase 3 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 8,500 participants
- Enrollment target
Study Summary
The primary objective of this study is to estimate the relative efficacy and assess the safety of CAIV-T compared to TIV.
Interventions
- DRUG Liquid CAIV-T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,500 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
What the finished NCT00128167 record still lists
NCT00128167 is an interventional study that assigns participants to a tested intervention. Its 8,500 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1002% higher).
The record links to 0 conditions, and to 1 intervention - of which Liquid CAIV-T is the first listed.
NCT00128167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00128167 about?
NCT00128167 is a clinical study titled "Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age". The primary objective of this study is to estimate the relative efficacy and assess the safety of CAIV-T compared to TIV.
What is the current status of trial NCT00128167?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 8,500 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00128167?
The interventions under investigation include: Liquid CAIV-T (DRUG).
Who is sponsoring clinical trial NCT00128167?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00128167's enrollment target sits among peer trials
8,500 32nd of 2000 higher than 1,969 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia